| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 01:50:14 UTC |
|---|
| Update Date | 2021-09-26 22:58:48 UTC |
|---|
| HMDB ID | HMDB0248488 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Antimycin A |
|---|
| Description | Antimycin A belongs to the class of organic compounds known as acylaminobenzoic acid and derivatives. These are derivatives of amino benzoic acid derivatives where the amine group is N-acylated. Based on a literature review very few articles have been published on Antimycin A. This compound has been identified in human blood as reported by (PMID: 31557052 ). Antimycin a is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Antimycin A is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CCCCCCC1C(OC(=O)CC(C)C)C(C)OC(=O)C(NC(=O)C2=CC=CC(NC=O)=C2O)C(C)OC1=O InChI=1S/C28H40N2O9/c1-6-7-8-9-11-20-25(39-22(32)14-16(2)3)18(5)38-28(36)23(17(4)37-27(20)35)30-26(34)19-12-10-13-21(24(19)33)29-15-31/h10,12-13,15-18,20,23,25,33H,6-9,11,14H2,1-5H3,(H,29,31)(H,30,34) |
|---|
| Synonyms | | Value | Source |
|---|
| N-{7-hexyl-4,9-dimethyl-8-[(3-methylbutanoyl)oxy]-2,6-dioxo-1,5-dioxonan-3-yl}-2-hydroxy-3-[(hydroxymethylidene)amino]benzene-1-carboximidate | HMDB | | Antimycin a | MeSH |
|
|---|
| Chemical Formula | C28H40N2O9 |
|---|
| Average Molecular Weight | 548.633 |
|---|
| Monoisotopic Molecular Weight | 548.273380876 |
|---|
| IUPAC Name | 3-(3-formamido-2-hydroxybenzamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl 3-methylbutanoate |
|---|
| Traditional Name | antimycin A |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCCCCCC1C(OC(=O)CC(C)C)C(C)OC(=O)C(NC(=O)C2=CC=CC(NC=O)=C2O)C(C)OC1=O |
|---|
| InChI Identifier | InChI=1S/C28H40N2O9/c1-6-7-8-9-11-20-25(39-22(32)14-16(2)3)18(5)38-28(36)23(17(4)37-27(20)35)30-26(34)19-12-10-13-21(24(19)33)29-15-31/h10,12-13,15-18,20,23,25,33H,6-9,11,14H2,1-5H3,(H,29,31)(H,30,34) |
|---|
| InChI Key | UIFFUZWRFRDZJC-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as acylaminobenzoic acid and derivatives. These are derivatives of amino benzoic acid derivatives where the amine group is N-acylated. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzoic acids and derivatives |
|---|
| Direct Parent | Acylaminobenzoic acid and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-amino acid ester
- Acylaminobenzoic acid or derivatives
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid or derivatives
- Salicylamide
- Salicylic acid or derivatives
- Benzamide
- Anilide
- Tricarboxylic acid or derivatives
- Benzoyl
- N-arylamide
- 1-hydroxy-4-unsubstituted benzenoid
- Fatty acid ester
- Phenol
- Fatty acyl
- Vinylogous acid
- Carboxamide group
- Carboxylic acid ester
- Lactone
- Secondary carboxylic acid amide
- Oxacycle
- Carboxylic acid derivative
- Organoheterocyclic compound
- Hydrocarbon derivative
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Organic oxide
- Organonitrogen compound
- Organooxygen compound
- Organopnictogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 20.6747 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.38 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3862.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 308.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 211.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 159.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 201.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 848.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1064.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 89.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1676.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 754.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2320.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 525.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 577.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 273.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 91.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 20.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Antimycin A,2TMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(NC=O)=C2O[Si](C)(C)C)[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4018.0 | Semi standard non polar | 33892256 | | Antimycin A,2TMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(NC=O)=C2O[Si](C)(C)C)[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 3793.0 | Standard non polar | 33892256 | | Antimycin A,2TMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(NC=O)=C2O[Si](C)(C)C)[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 5067.5 | Standard polar | 33892256 | | Antimycin A,2TMS,isomer #2 | CCCCCCC1C(=O)OC(C)C(NC(=O)C2=CC=CC(N(C=O)[Si](C)(C)C)=C2O[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 3993.2 | Semi standard non polar | 33892256 | | Antimycin A,2TMS,isomer #2 | CCCCCCC1C(=O)OC(C)C(NC(=O)C2=CC=CC(N(C=O)[Si](C)(C)C)=C2O[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 3812.4 | Standard non polar | 33892256 | | Antimycin A,2TMS,isomer #2 | CCCCCCC1C(=O)OC(C)C(NC(=O)C2=CC=CC(N(C=O)[Si](C)(C)C)=C2O[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 5012.9 | Standard polar | 33892256 | | Antimycin A,2TMS,isomer #3 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C)=C2O)[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 3810.2 | Semi standard non polar | 33892256 | | Antimycin A,2TMS,isomer #3 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C)=C2O)[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 3799.2 | Standard non polar | 33892256 | | Antimycin A,2TMS,isomer #3 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C)=C2O)[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4899.0 | Standard polar | 33892256 | | Antimycin A,3TMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C)=C2O[Si](C)(C)C)[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 3874.4 | Semi standard non polar | 33892256 | | Antimycin A,3TMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C)=C2O[Si](C)(C)C)[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 3840.8 | Standard non polar | 33892256 | | Antimycin A,3TMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C)=C2O[Si](C)(C)C)[Si](C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4653.5 | Standard polar | 33892256 | | Antimycin A,2TBDMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(NC=O)=C2O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4416.8 | Semi standard non polar | 33892256 | | Antimycin A,2TBDMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(NC=O)=C2O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4147.9 | Standard non polar | 33892256 | | Antimycin A,2TBDMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(NC=O)=C2O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 5081.2 | Standard polar | 33892256 | | Antimycin A,2TBDMS,isomer #2 | CCCCCCC1C(=O)OC(C)C(NC(=O)C2=CC=CC(N(C=O)[Si](C)(C)C(C)(C)C)=C2O[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4335.0 | Semi standard non polar | 33892256 | | Antimycin A,2TBDMS,isomer #2 | CCCCCCC1C(=O)OC(C)C(NC(=O)C2=CC=CC(N(C=O)[Si](C)(C)C(C)(C)C)=C2O[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4143.7 | Standard non polar | 33892256 | | Antimycin A,2TBDMS,isomer #2 | CCCCCCC1C(=O)OC(C)C(NC(=O)C2=CC=CC(N(C=O)[Si](C)(C)C(C)(C)C)=C2O[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 5077.3 | Standard polar | 33892256 | | Antimycin A,2TBDMS,isomer #3 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C(C)(C)C)=C2O)[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4232.9 | Semi standard non polar | 33892256 | | Antimycin A,2TBDMS,isomer #3 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C(C)(C)C)=C2O)[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4132.0 | Standard non polar | 33892256 | | Antimycin A,2TBDMS,isomer #3 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C(C)(C)C)=C2O)[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4959.2 | Standard polar | 33892256 | | Antimycin A,3TBDMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C(C)(C)C)=C2O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4409.9 | Semi standard non polar | 33892256 | | Antimycin A,3TBDMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C(C)(C)C)=C2O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4320.2 | Standard non polar | 33892256 | | Antimycin A,3TBDMS,isomer #1 | CCCCCCC1C(=O)OC(C)C(N(C(=O)C2=CC=CC(N(C=O)[Si](C)(C)C(C)(C)C)=C2O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)OC(C)C1OC(=O)CC(C)C | 4761.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Antimycin A GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Antimycin A GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Antimycin A GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Antimycin A GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Antimycin A GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Antimycin A GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Antimycin A 40V, Negative-QTOF | splash10-0006-0900000000-be0a5df9a6a3d546a225 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Antimycin A 20V, Negative-QTOF | splash10-0hft-0490100000-da702b1608e13566ff01 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Antimycin A 10V, Negative-QTOF | splash10-0002-0190180000-5545b4f97aa516fff94c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antimycin A 10V, Positive-QTOF | splash10-0002-1601790000-88442a36daeeb711d0a3 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antimycin A 20V, Positive-QTOF | splash10-03dr-3900300000-1e7a9140da4b1671cb42 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antimycin A 40V, Positive-QTOF | splash10-0006-9602100000-e2c7a8625c4d14160203 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antimycin A 10V, Negative-QTOF | splash10-0002-0000390000-defa144f9ea9f9e14f40 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antimycin A 20V, Negative-QTOF | splash10-0006-9201700000-f0a797266254aded2312 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Antimycin A 40V, Negative-QTOF | splash10-0006-9610000000-299092ffcb13b3cb8fb8 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|